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Abstract
Background: We have previously demonstrated that PDGF receptor activation indirectly inhibits
N-methyl-D-aspartate (NMDA) currents by modifying the cytoskeleton. PDGF receptor ligand is
also neuroprotective in hippocampal slices and cultured neurons. PDGF receptors are tyrosine
kinases that control a variety of signal transduction pathways including those mediated by PLCγ. In
fibroblasts Src and another non-receptor tyrosine kinase, Abelson kinase (Abl), control PDGF
receptor regulation of cytoskeletal dynamics. The mechanism whereby PDGF receptor regulates
cytoskeletal dynamics in central neurons remains poorly understood.
Results: Intracellular applications of active Abl, but not heat-inactivated Abl, decreased NMDA-
evoked currents in isolated hippocampal neurons. This mimics the effects of PDGF receptor
activation in these neurons. The Abl kinase inhibitor, STI571, blocked the inhibition of NMDA
currents by Abl. We demonstrate that PDGF receptors can activate Abl kinase in hippocampal
neurons via mechanisms similar to those observed previously in fibroblasts. Furthermore, PDGFβ
receptor activation alters the subcellular localiz a t i o n  o f  A b l .  A b l  k i n a s e  i s  l i n k e d  t o  a c t i n
cytoskeletal dynamics in many systems. We show that the inhibition of NMDA receptor currents
by Abl kinase is blocked by the inclusion of the Rho kinase inhibitor, Y-27632, and that activation
of Abl correlates with an increase in ROCK tyrosine phosphorylation.
Conclusion: This study demonstrates that PDGFβ receptors act via an interaction with Abl kinase
and Rho kinase to regulated cytoskeletal regulation of NMDA receptor channels in CA1 pyramidal
neurons.
Background
Long-term potentiation (LTP) and long-term depression
(LTD) are forms of plasticity which occur at the synapses
between CA3 and CA1 pyramidal neurons of the hippoc-
ampus and they underlie some forms of spatial learning
and memory [1,2]. Their induction is dependent upon the
activation of N-methyl-D-aspartate (NMDA) receptors
[3,4]. These receptors make a relatively minor contribu-
tion to the basal excitatory synaptic potential but they are
recruited during high frequency stimulation when the
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depolarizations summate and cause a relief of their block
my Mg2+. The NMDA receptor currents must be further
enhanced during the high frequency stimulation by the
calcium-dependent activation of Pyk2 and Src kinases in
order to induce LTP [5]. Src is brought into proximity of
the NMDA receptors through its binding to ND2, a pro-
tein which serves as a structural and morphological scaf-
fold for the regulation of NMDA receptors by Src [6]. A
variety of Gα q-coupled receptors stimulate phospholi-
pase C (PLC) β and PKC and enhance NMDA receptors by
targeting the Pyk2/Src regulation of NMDA receptors in
CA1 neurons [7].
NMDA receptors bind directly to a variety of other scaf-
folding proteins including actin binding proteins [8].
Actin binding proteins link these receptors to the actin
cytoskeleton and these protein-protein interactions are
regulated by calmodulin binding and the influx of cal-
cium via NMDA receptors such that the activity of these
receptors is closely linked to actin cytoskeletal dynamics
[8]. This actin anchoring may be permissive for the mech-
ano-sensitivity of NMDA receptors [9] and is required for
the inhibition of NMDA receptors by myosin light chain
kinase and F-actin [10]. Therefore, actin cytoskeleton
dynamics are pivotal to regulation of NMDA receptors.
LTD of the NMDA receptor-mediated component of the
excitatory synaptic postsynaptic currents (epscs) is
blocked by inhibition of serine-threonine phosphatases
and can be prevented by using agents that stabilize the
cytoskeleton in CA1 neurons [11]. We have previously
shown that stimulation of the dopamine D2 receptor (a
Gαi-coupled receptor) results in transactivation of platelet
derived growth factor β (PDGFβ) receptors [12,13] and in
turn PDGFβ receptor activation causes a long-lasting
depression of NMDA receptor currents in CA1 neurons
[12,14,15] that resembles the LTD of NMDA receptor
epscs. For example, inhibition of NMDA receptor currents
by the PDGFβ receptor is prevented by the serine-threo-
nine phosphatase inhibitor calyculin A and is also
dependent on the stability of the actin cytoskeleton
[14,15]. The mechanism(s) whereby PDGFβ receptor sig-
naling modifies the actin cytoskeleton in CA1 neurons to
regulate NMDA receptor currents is unknown, however
the inhibition does require activation of PLCγ and it is
both calcium- and Src-dependent [14].
In a variety of cell types PDGFβ receptors form a signal
complex with PLCγ, Src and a second tyrosine kinase,
Abelson (Abl) kinase and downstream signaling is
dependent upon interplay between of these enzymes [16].
Abl kinase is implicated in mechanisms of synaptic plas-
ticity, plays a crucial role in growth cone motility, and is
involved dendritic branching in developing neurons [17-
20]. In Abl and Abl-related gene (Arg) double-knock out
mice, the extent of dendritic branching in substantially
reduced [20] and treatment of developing cultured neu-
rons with the Abl inhibitor, STI571, decreases the com-
plexity of neuronal dendritic branching via an increase in
RhoA activity [21] and possible activation of Rho-associ-
ated kinase (ROCK) [22-24]. Despite the identification of
Abl as an important regulator of several neuronal proc-
esses, it remains unclear how Abl is activated in neurons.
In several systems, Abl kinases are also required for Rho-
family GTPase coupling to the actin cytoskeleton and can
reciprocally signal to ROCK [25]. Given the signaling con-
nection between PDGFβ receptors and Abl as well as the
evidence of Abl kinase regulation of neuronal signaling
and development, we examined the possibility that in
CA1 neurons Abl kinase is activated downstream of
PDGFβ receptors and that Abl acting with ROCK is
responsible for the alterations in actin cytoskeleton that
underlie long-term depression of NMDA receptor activity.
Results
Abl kinase inhibits NMDA-evoked currents
To examine the effects of Abl on NMDA currents, we
acutely dissociated CA1 neurons from 2–3 week old Wis-
tar rats. Whole cell NMDA currents were evoked by apply-
ing 50 μM NMDA and 0.5 μM glycine for 2 seconds every
minute. Intracellular application of 0.5 μg/mL active Abl
kinase resulted in a time-dependent depression of NMDA
currents (Figure 1A). After 25 minutes, NMDA currents
were reduced by 53 ± 5% (Figure 1A, B). In contrast, the
inclusion of heat-inactivated Abl kinase in the patch
pipette did not depress NMDA currents such that peak
currents were maintained for the 25 minutes of recording
(104 ± 8%, Figure 1A, C).
Chromosomal translocations involving Abl kinase result
in a constitutively active kinase that causes chronic mye-
loid leukemia [26]. Recently, STI571 (imatinib mesylate,
Gleevec™) has been used to successfully treat patients with
this form of leukemia. STI571 is a potent inhibitor of Abl
kinase as well as PDGFβ receptors with an IC50 value for
Abl in the low micromolar range [27,28]. Active Abl
kinase was introduced into the cell via the patch pipette
whereas STI571 was added to the ECF. STI571 (2.5 μM)
completely blocked the inhibition of NMDA currents by
Abl kinase (Figure 1D). The inhibition of NMDA currents
by Abl returned upon the washout of STI571 from the ECF
(Figure 1E). These data show that STI571 inhibits the
depression of NMDA currents induced by Abl and that
this inhibition is reversible.
PDGF receptors activate Abl in the hippocampus
Multiple signaling pathways including those initiated by
PDGFβ receptors can activate the cytoplasmic pool of Abl
kinase. To investigate the possibility that PDGFβ receptor
activation could activate Abl kinase in hippocampal neu-Molecular Brain 2008, 1:20 http://www.molecularbrain.com/content/1/1/20
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rons, we incubated acutely dissected CA1 hippocampal
slices with the PDGFβ receptor ligand, PDGF-BB. We then
incubated CA1 hippocampal cell lysates with immobi-
lized anti-PDGFβ receptor antibodies to examine whether
PDGFβ receptors and Abl kinase physically associate in
hippocampal neurons. Abl kinase was immunoprecipi-
tated with PDGFβ receptors from hippocampal neurons
and this association was significantly diminished upon
PDGF-BB treatment of the hippocampal slices (Figure 2A,
Abl immunoreactivity in PDGF receptor antibody pull-
down was 0.65 ± 0.12 fold vs. control, n = 7, p < 0.05,
unpaired Student's t-test). This observation supports the
interpretation that Abl associates with PDGFβ receptors
and is released upon activation of the receptor. To further
examine the ability of PDGFβ receptors to activate Abl
kinase in hippocampal neurons, we monitored the phos-
phorylation state of Abl kinase after incubation of hippoc-
ampal slices with PDGF-BB. Treatment with PDGF-BB for
10 minutes enhanced the tyrosine phosphorylation of Abl
kinase (Figure 2B, 4.2 ± 0.8 fold vs. control, n = 7, p < 0.05
Intracellular application of Abl decreases NMDA-evoked currents Figure 1
Intracellular application of Abl decreases NMDA-evoked currents. A) Active (black square) or heat-inactivated 
(denat., white square) Abl kinase (0.5 μg/mL) was included in the intracellular solution. NMDA-evoked currents were recorded 
once every minute and peak currents were normalized to the average of the first five currents recorded. At 25 minutes (b) Abl 
significantly reduced NMDA-evoked currents (p < 0.05, Student's t-test, n = 6). B, C) Representative currents from currents 
recorded in the presence of active Abl kinase or heat-inactivated kinase at t = 3 minutes (a) or t = 25 minutes (b). D) NMDA-
evoked currents were recorded with active Abl kinase applied intracellularly in the ICF in the absence (black square) or pres-
ence (black triangle) of the Abl kinase inhibitor, STI571, applied in the ECF bath (n = 6). E) NMDA-evoked currents were 
recorded with active Abl kinase applied intracellularly in the ICF in the absence (black square) or presence (black triangle) of 
the Abl kinase inhibitor, STI571, applied in the ECF bath for 25 minutes (STI571), followed by a 25 minute washout period 
(WO) during which control ECF solution was applied (n = 6).Molecular Brain 2008, 1:20 http://www.molecularbrain.com/content/1/1/20
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unpaired Student's t-test). These data show that treatment
of CA1 hippocampal slices results in an increase in Abl
tyrosine kinase phosphorylation and a change in the asso-
ciation of Abl kinase with the PDGF receptor.
We have previously demonstrated that both Src kinase
and PLCγ are required for the inhibition of NMDA-evoked
currents by PDGFβ receptors [14,29]. PDGFβ receptor
activation activates Abl in HEK293 cells in a Src- and
PLCγ-dependent manner [30,31]. PDGF-BB treatment of
hippocampal slices enhanced the phosphorylation of
both the tyrosine 416 (associated with increased Src activ-
ity) and tyrosine 527 (associated with decreased Src activ-
ity (Figure 2C) [32,33]. Consistent with previous studies
examining the activation of Abl kinase, CA1 lysates
immunoprecipitated with anti-Abl antibodies showed a
decrease in the interactions of Abl with PLCγ (Figure 2D)
and Src (not shown). Taken together, these results suggest
PDGF receptors activate Abl kinase in hippocampal neurons Figure 2
PDGF receptors activate Abl kinase in hippocampal neurons. Acutely dissected hippocampal CA1 slices were incu-
bated in the absence or presence of 10 ng/mL PDGF-BB for 10 minutes. A) Slices were homogenized and the lysate was incu-
bated with anti-PDGFβ receptor antibodies precoupled to agarose beads. Total lysate and immunoprecipitated samples were 
immunoblotted with anti-Abl (top) or anti-PDGFβ receptor (bottom). Blots are representative of 7 experiments. B) Slices 
were homogenized and the lysates were immunoprecipitated with an anti-Abl antibody. Lysates and immunoprecipitates were 
resolved via SDS-Page electrophoresis and immunoblotted with anti-phospho-tyrosine (PY) or anti-Abl kinase antibodies. Blots 
are representative of 7 experiments. C) Anti-Src antibodies were used to immunoprecipitated Src after treatment of slices 
with 10 ng/mL PDGF-BB for 10 minutes. Immunoprecipitated samples were separated by SDS-electrophoresis and membranes 
were probed with anti-tyrosine 146 (Src-416), anti-tyrosine-527 (Src-527), or anti-Src (Src) antibodies. Blots are representa-
tive of 4–6 experiments. D) Lysates were immunoprecipitated with anti-Abl antibodies and membranes were probed with anti-
PLCγ antibodies. Blot is representative of 5 experiments.Molecular Brain 2008, 1:20 http://www.molecularbrain.com/content/1/1/20
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that Abl interacts with PDGFβ receptors, PLCγ, and Src in
hippocampal neurons and activation of PDGFβ receptors
decreases the association of Abl with these interacting
partners as well as causing an increase in the tyrosine
phosphorylation of Abl kinase.
PDGF receptor activation decreases the cytoplasmic pool 
of Abl kinase
Abl kinase is localized in both the synaptosomal and post-
synaptic density fractions in adult rat brain homogenates
[34] and Abl immunoreactivity is detected pre- and post-
synaptically [18]. Upon stimulation of hippocampal
slices with PDGF-BB, Abl kinase immunoreactivity
decreased in both the S2 (cytosolic) and S3 (light mem-
brane) fractions (Figure 3A, B). There was a trend towards
an increase in immunoreactivity for Abl kinase in the tri-
ton-insoluble fraction (Figure 3A, B), suggesting that Abl
kinase is moving from the cytosolic and light membrane
fraction to the triton-insoluble fraction. Conversely, it is
possible that Abl is being rapidly degraded in the S2 and
S3 fractions. The NR1 subunit of the NMDA receptor was
not significantly altered with respect to subcellular locali-
zation (Table 1).
Abl inhibition of NMDA currents is blocked by the ROCK 
inhibitor Y-27632
Both PDGFβ receptors and Abl kinase are involved in
cytoskeletal dynamics in multiple systems [19,35,36].
Incubation of acutely dissociated hippocampal neurons
with the Rho kinase (ROCK) inhibitor, Y-27632 (IC50 ~
0.3  μM) [37], attenuated the ability of intracellularly-
applied Abl kinase to inhibit NMDA currents (Figure 4A,
B). PDGF-BB also enhanced the tyrosine phosphorylation
of ROCK by 1.87 +/- 0.25 (Figure 4C, p < 0.05, Student's
unpaired t-test). Furthermore, ROCK underwent a similar
change in subcellular localization as Abl kinase (Table 1).
Abelson kinase is also associated with actin cytoskeletal
dynamics via its association with WAVE1. Interestingly,
Abl associates with WAVE1 in hippocampal neurons and
treatment of hippocampal slices with PDGF-BB decreased
the association of Abl with WAVE1 (Figure 4D) [38]. The
ability of the ROCK inhibitor to block the Abl inhibition
of NMDA currents implies that the inhibition of NMDA
currents may be dependent on changes Abl-mediated
alterations in the actin cytoskeleton.
Discussion
In the central nervous system, Abl kinase is involved with
several crucial physiological processes. However the
majority of studies have used transgenic deletions of Abl
and/or Arg or small molecule inhibitors of the kinases
[20,21]. Mechanisms of Abl regulation by cell surface
receptors and intracellular signaling pathways in neurons
remain unclear, and the role of Abl in post-synaptic neu-
ronal signaling, specifically in NMDA receptor regulation,
is unknown. We demonstrate that active Abl kinase inhib-
its NMDA currents in isolated hippocampal neurons. The
inhibition of NMDA currents by Abl is completely and
reversibly blocked by STI571, an Abl kinase (and PDGFβ
receptor kinase) inhibitor. Although Abl and PDGFβ
receptors may be inhibited by STI571, we have not previ-
ously observed a significant basal activity level of PDGF
receptors in hippocampal neurons in previously pub-
lished reports [12,13] and unpublished observations.
Several lines of evidence link cell surface receptors to the
activation of Abl kinase. The most detailed studies on the
regulation of Abl involve the activation of Abl by PDGFβ
receptors in fibroblasts [30,31]. In hippocampal neurons,
Abl appears to be regulated by similar mechanisms. Abl
associates with PDGFβ receptors, PLCγ, and Src in CA1
hippocampal neurons. Upon treatment of acutely isolated
hippocampal slices with PDGF-BB, the association of Abl
with each of these proteins is decreased and this coincides
with an increase in tyrosine phosphorylation of Abl
kinase.
Interestingly, PDGF-BB treatment increased the phospho-
rylation of Src at both tyrosine 416 (tyrosine phosphor-
ylation here potentiates Src activity) and 527 (tyrosine
phosphorylation inhibits Src activity) [39]. Activation of
Src kinase via the phosphorylation of tyrosine 416 is asso-
ciated with a potentiation of NMDA receptor currents and
an increase in long-term potentiation [40-42]. However,
we have previously demonstrated that application of
PDGF-BB inhibits NMDA currents and that this inhibition
is Src-dependent [14]. The identification of Abl as a down-
stream target in hippocampal neurons coupled with the
requirement of Src to fully activate Abl after PDGF recep-
tor activation may help reconcile the apparent contradic-
tion in the requirement of Src for an inhibition of NMDA
receptor currents by PDGF receptor activation and the
direct potentiation of NMDA receptors by Src [14]. Recent
work by Veracini et al. have identified least two distinct
subcellular pools of Src mediating distinct signaling path-
ways in NIH 3T3 cells [43,44]. The increases in tyrosine
phosphorylation at both the inhibitory and activation
tyrosine residues of Src in the hippocampus suggest the
intriguing possibility that two or more pools of Src may be
present in neurons as well. One pool interacting with the
PDGFβ receptor and leading to a PLCγ/Abl/Src complex
that signals to the cytoskeleton via ROCK (with a resulting
inhibition of NMDA receptors) and the other pool inter-
acting directly with ND2 and the NMDA receptor complex
to enhance NMDA receptor activity during LTP.
In cortical neurons, Abl and Arg are required for normal
dendritic branching and are activated downstream of
integrin receptors [17,20]. The regulation of dentritic
spines and synapses are also important for synaptic plas-Molecular Brain 2008, 1:20 http://www.molecularbrain.com/content/1/1/20
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Abl kinase immunoreactivity is decreased in the S2 and S3 fractions after PDGFβ receptor activation Figure 3
Abl kinase immunoreactivity is decreased in the S2 and S3 fractions after PDGFβ receptor activation. A) Hip-
pocampal slices were treated for 10 minutes with 10 ng/mL PDGF-BB, were homogenized, and S2, S3, and P3 fractions were 
prepared as described in the methods section. Equal amounts of total protein from each fraction were resolved on SDS gels, 
transferred to nitrocellulose membranes, and immunoblotted with anti-Abl or anti-PSD-95 antibodies (n = 6). B) PDGF-BB 
treated fractions were normalized to control for each fractionation sample. Data represent the mean +/- standard error for 6 
independent experiments. PDGF-BB treatment significantly decreased Abl kinase immunoreactivity in the S2 and S3 fractions, * 
p < 0.05, Student's unpaired t-test.Molecular Brain 2008, 1:20 http://www.molecularbrain.com/content/1/1/20
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ticity in mature neurons, and depends heavily on actin
cytoskeleton dynamics [45,46]. In contrast to previous
reports suggesting ROCK activity is inversely proportional
to Abl activity [23,47,48], treatment of hippocampal slices
with PDGF-BB increased ROCK tyrosine phosphoryla-
tion. Furthermore, the ROCK inhibitor attenuated Abl-
induced decreases in NMDA-evoked currents. These
observations show that ROCK is required for Abl-medi-
ated changes in the actin cytoskeleton that leads to inhibi-
tion of NMDA currents and that Abl-mediated inhibition
of NMDA receptor currents requires RhoGTPase and
ROCK signaling (Figure 5). Therefore, in addition to
being crucial for neuronal development, Abl kinase regu-
lates NMDA function in mature neurons and links PDGFβ
receptor signaling to the actin cytoskeleton. Our results
place Abl at an important intersection between alterations
in the neuronal cytoskeleton and regulation of NMDA
receptors.
Conclusion
PDGF-BB treatment decreased the association of Abl with
PDGFβ receptors. Furthermore, PDGF-BB treatment
reduced the association of Abl with PLCγ and Src, suggest-
ing that Abl is activated in hippocampal neurons in a
manner similar as previously reported in non-neuronal
cells. PDGF-BB treatment of hippocampal slices also
induced a translocation of Abl from the cytosolic and
membrane fraction to the triton-insoluble fraction. Previ-
ous studies have suggested that PDGFβ receptor activation
ultimately alters NMDA receptor signaling by inducing
changes in cytoskeletal dynamics and Abl kinase is linked
in several systems to actin dynamics. Similar to extracellu-
lar treatment of neurons with PDGF-BB, the inclusion of
Abelson kinase in the patch pipette robustly inhibited
NMDA-evoked currents in isolated CA1 neurons and this
inhibition was blocked by treatment of neurons with the
Abl inhibitor STI571 and the ROCK inhibitor, Y-27632.
These results suggest that PDGFβ receptors activate Abl
kinase in hippocampal neurons and that Abl links PDGFβ
receptor signaling to changes in the neuronal cytoskeleton
that ultimately lead to changes in NMDA receptor signal-
ing.
Methods
Reagents and antibodies
Active Abl kinase (mouse) was purchased from Upstate
Biotechnology/Millipore (Belerica, MA). Each lot of active
Abl kinase was tested for phosphorylation of a peptide
substrate in an in vitro kinase assay (by the manufacturer).
Briefly, each lot of Abl kinase had a specific activity
(~1750 units/mg) where 1 unit is defined as incorporating
1 nmol phosphate into 50 μM Abltide (EAIYAAPFAKKK)
per minute at 30°C in the presence of 100 μM ATP. PDGF-
BB was purchased from R&D Systems (Minneapolis, MN,
USA). Y-27632 was purchased from Calbiochem (San
Diego, CA). NMDA, glycine, and all other chemical rea-
gents were purchased from Sigma (St. Louis, MO, USA).
Antibodies used include those raised against PDGFβ
receptor (Epitomics, California, USA), Abelson kinase
(Sigma), Src (Cell Signaling, Danvers, MDA) and phos-
pho-Y416 and Y527 Src (Biosource, Carlsbad, CA), and
phospho-tyrosine antibody (Santa Cruz, La Jolla, CA),
and PLCγ, ROCK, and WAV1 (Cell signaling). For the
immunoprecipitation of PDGFβ receptors, an agarose-
conjugated anti-PDGFβR antibody from Santa Cruz was
employed.
Cell isolation and whole-cell recording
CA1 neurons were isolated from hippocampal slices of
postnatal day 14–21 Wistar rats as previously described
[49]. The extracellular solution was composed of 140 mM
NaCl, 1.3 mM CaCl2, 25 mM N-2-Hydroxyethylpipera-
zine-N'-thanesulfonic acid (HEPES), 33 mM glucose, 5.4
mM KCl, and 0.5 μM tetrodotoxin, and 0.5 μM glycine,
with pH of 7.3–7.4 and osmolarity ranging from 320–330
mOsm. Recordings were done at room temperature. The
membrane potential was held at -60 mV throughout the
recordings and with a voltage step of 10 mV was applied
prior to NMDA application to monitor series resistance.
Recordings were rejected if a series resistance change
greater than 10% was observed. The intracellular solution
consisted of 11 mM Ethyleneglycol-bis-(α-amino-ethyl
ether) N,N'-tetra-acetic acid (EGTA) as intracellular cal-
cium chelating buffer, 10 mM HEPES, 2 mM MgCl2, 2
mM Tetraethyl ammonium chloride (TEA-Cl) to block K+
channel, 1 mM CaCl2, 140 mM CsF, and 4 mM K2ATP.
NMDA currents were evoked by rapid application of
NMDA solution delivered from a multi-barreled fast per-
fusion system for 2 seconds in every minute. The solution
was delivered at a rate of approximately 1 ml per minute.
Table 1: The effect of PDGF-BB on the subcellular fractionation 
of PDGFβ receptors, ROCK, and NR1
Protein Change in localization after PDGF-BB treatment
S2 S3 P3
PDFGβ receptor n/a 63 ± 15%a 136 ± 31%
ROCK 60 ± 12%a 66 ± 30% 125 ± 30%
NR1 n/a 81 ± 36% 130 ± 30%
Hippocampal slices were treated for 10 minutes with 10 ng/mL 
PDGF-BB, were homogenized, and S2, S3, and P3 fractions were 
prepared as described in the methods section. Equal amounts of total 
protein from each fraction were resolved on SDS gels, transferred to 
nitrocellulose membranes, and immunoblotted with anti- PDFGβ 
receptor (n = 4), anti-ROCK (n = 3), or anti-NR1 (n = 3) antibodies. 
Data represent the mean +/- standard error, a p < 0.05, Student's 
unpaired t-test.Molecular Brain 2008, 1:20 http://www.molecularbrain.com/content/1/1/20
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Abl or heat-inactivated Abl (0.5 μg/mL) was added to the
ICF.
Immunoprecipitation and western blotting
The CA1 region of the hippocampus was microdissected
from day 14–22 Wistar rat pups. CA1 slices (5–10 per con-
dition) were incubated for 10 minutes with vehicle or
PDGF-BB. Slices were washed in ice-cold ECF and homog-
enized in solubilization buffer (20 mM Tris, pH = 7.5, 150
mM NaCl, 1 mM EDTA, 1 mM EGTA, 30 mM Na pyro-
phosphate, 1 mM βglycerophosphate, 1% Triton (1% NP-
40 was substituted for immunoprecipitation), 1 mM
Na3VO4, and MINI cocktail (Roche, Mannheim, Ger-
many). Samples were centrifuged at 14,000 × g for 20
minutes and lysates were used for protein determination.
Total protein concentration was determined by BCA Pro-
tein Assay (Pierce, Rockford, Il, USA). For Western blot,
equal amounts of protein were loaded for each sample.
For immunoprecipitations, lysate protein concentrations
were normalized and lysates were incubated with primary
The ROCK inhibitor, Y-27632, attenuates Abl kinase-induced inhibition of NMDA evoked currents Figure 4
The ROCK inhibitor, Y-27632, attenuates Abl kinase-induced inhibition of NMDA evoked currents. A) Abl 
kinase (black triangle) or control (white square) was included in the intracellular solution. NMDA-evoked currents were 
recorded once every minute and peak currents were normalized to the average of the first five currents recorded (n = 7).). At 
25 minutes Abl significantly reduced NMDA-evoked currents (p < 0.05, Student's t-test, n = 5), B) NMDA-evoked peak cur-
rents were recorded every minute in the presence of 1 μM Y-27632 with control (ROCK inhibitor, white square) or Abl 
kinase (+Abelson, black triangle) included in the intracellular solution. Peak currents were normalized to the average of the 
first five currents recorded (n = 5). C) Slices were homogenized and the lysates were immunoprecipitated with an anti-ROCK 
antibody. Lysates and immunoprecipitates were resolved via SDS-Page electrophoresis and immunoblotted with anti-phospho-
tyrosine (PY) or anti-ROCK antibodies. Blots are representative of 4 experiments. D) Slices were homogenized and the lysates 
were immunoprecipitated with an anti-Abl antibody. Lysates and immunoprecipitates were resolved via SDS-Page electro-
phoresis and immunoblotted with anti-WAVE1 antibody. Blot is representative of 4 experiments.Molecular Brain 2008, 1:20 http://www.molecularbrain.com/content/1/1/20
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antibody and protein A/G beads (Sigma) overnight at
4°C. Beads were washed three times and boiled in SDS
loading buffer for 5 minutes before separation by SDS
page electrophoresis. Proteins were transferred to nitrocel-
lulose membranes, blocked with 5% non-fat dry milk in
Tris-buffered saline for 1 hr at room temperature or over-
night at 4°C, and incubated in primary antibodies for 1 hr
or overnight at 4°C. Membranes were washed three times
in Tris-buffered saline with 0.1% Tween-20, incubated
with HRP-conjugated secondary antibodies for 1 hr,
washed again, and bound antibodies were visualized by
the enhanced chemiluminescence method. Densitometric
analysis of Western blots was performed using the Kodak
Image Station 2000R software.
Subcellular fractionation
Hippocampal tissue was incubated with vehicle or PDGF-
BB and the tissue was dounce homogenized in fractiona-
tion buffer 1 to yield the S1 fraction (buffer 1: 0.32 M
sucrose, 4 mM HEPES, pH 7.3, MINI protease inhibitor
cocktail 1:10, and 1 mM Na3VO4). The homogenized tis-
sue was centrifuged at 1000 × g for 10 minutes at 4
degrees. The supernatant was retained and centrifuged at
14,000 × g for 20 minutes. The supernatant (S2) was
retained and the insoluble material was resuspended in
fractionation buffer 2 (buffer 1 + 1% triton). The resus-
pended mixture was centrifuged at 100,000 × g for 60
minutes and the supernatant (S3, triton-soluble mem-
brane fraction) was retained. The pellet (P3) was resus-
pended and dissolved in fractionation buffer 3 (buffer 1 +
0.5% SDS + 1% deoxycholate). Protein concentration was
determined by BCA protein assay and lysates were sub-
jected to Western blotting as described above.
Statistical analysis
Statistical analysis of the data was completed using Prism®
GraphPad program. Graphs and sample tracings were
made from Origin® program. All data was reported as
mean ± SEM. Significance level was set at α = 0.05. Data
was analyzed by Student's t-test or unpaired Student's t-
test where appropriate.
Animals
All animal experiments were performed in agreement
with the guidelines of the policies on the Use of Animal at
the University of Toronto.
Abbreviations
NMDA: N-methyl-D-aspartate; PLC: phospholipase C;
PDGF: platelet-derived growth factor; ROCK: Rho-associ-
ated kinase
Abelson kinase associates with PDGFβ receptors and inhibits NMDA receptor currents in a ROCK-dependent manner Figure 5
Abelson kinase associates with PDGFβ receptors and inhibits NMDA receptor currents in a ROCK-dependent 
manner. Abelson kinase (Abl) physically associates with PDGFβ receptors, PLCγ, and Src in hippocampal neurons. Upon acti-
vation of PDGFβ receptors, Abelson kinase is tyrosine-phosphorylated and dissociates from the receptor. Introduction of 
Abelson kinase into isolated hippocampal neurons robustly inhibits NMDA receptor currents in a ROCK-dependent manner, 
possibly through changes in the actin cytoskeleton.Molecular Brain 2008, 1:20 http://www.molecularbrain.com/content/1/1/20
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